Sandoz/B-ORG AG/I-ORG ,/O a/O major/O Swiss/O chemical/O and/O pharmaceutical/O group/O ,/O said/O that/O its/O group/O sales/O rose/O 25/O %/O to/O 9.482/O billion/O francs/O -LRB-/O $/O 5.80/O billion/O -RRB-/O in/O the/O first/O nine/O months/O of/O this/O year/O ,/O with/O strong/O gains/O in/O all/O divisions/O ./O
A/O year/O earlier/O sales/O totaled/O 7.567/O billion/O francs/O ./O
Positive/O currency/O rates/O and/O strong/O sales/O growth/O led/O to/O a/O substantial/O rise/O in/O consolidated/O profit/O in/O the/O period/O ,/O although/O the/O company/O did/O n't/O provide/O figures/O ,/O as/O is/O customary/O with/O Swiss/O companies/O ./O
Sandoz/B-ORG said/O it/O expects/O a/O ``/O substantial/O increase/O ''/O in/O consolidated/O profit/O for/O the/O full/O year/O ,/O barring/O major/O currency/O rate/O changes/O ./O
